Arkolith/Insider Trading/INO/Form 4

Zoth Lota S.

DirectorINOVIO PHARMACEUTICALS, INC. (INO) · full profile →Form 4 · filed Jan 5, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2022Sell(S)961$5.01$5K25K
Jan 3, 2022Option exercise(M)4K——26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2022Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001055726-22-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML